Kasner, S., Swaminathan, B., Lavados, P., Sharma, M., Muir, K., Veltkamp, R., Ameriso, S., Endres, M., Lutsep, H., Messé, S., Spence, J., Nedeltechev, K., Perera, K., Santo, G., Olavarria, V., Lindgren, A., Bangdiwala, S., Shoamanesh, A., Berkowitz, S., Mundl, H., Connolly, S., Hart, R.,
NAVIGATE ESUS Investigators:
Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: a prespecified subgroup analysis from the NAVIGATE ESUS trial.
Lancet Neurol. 17 (12), 1053-1060, 2018.